Transforming health, healthcare and drug discovery through the power of genomics
Global
Joined April 2015
- Tweets753
- Following867
- Followers2.8K
- Likes361
Pinned Tweet
1/10 We’re excited to announce the publication of our work with @StanfordMed, examining the premature deaths that would be saved if PRS-guided screening was introduced across seven common disease screening programs
nature.com/articles/s41467-0…
Watch: Our CEO Professor Sir Peter Donnelly's interview for @techUK President's Awards 2026. Following this, Genomics was named Business of the Year 2026 by @BBCRadio4 - listen and watch below, links in thread! #techUK #PresidentsAwards #Genomics #tech #BBC #TheBottomLine #Health
Listen: Genomics named Business of the Year 2026 @BBCRadio4. We were nominated by business leaders including Deputy President of @techUK following @genemodeller President's Award win for the Economy bbc.co.uk/sounds/play/m002z7…
We're heading to @HLTHEVENT in Amsterdam - you can find us on the Main Stage and on the Pharma Summit stage this Wednesday! 🚀 #HLTHEurope
Our CEO and Co-Founder Prof Sir @genemodeller had the honour of pitching at the OFI VC Health Tech Showcase, hosted by the @GOVUK @UKinvestoffice in partnership with @LSEplc
#TechBio #HealthTech #Biotech #Genomics #OFI #LondonStockExchange #Investment #LifeSciences
The East Coast US Launch of #MystraAI took place at #FOGBoston this afternoon! ✨Our VP of Life Sciences, Alexandra Fish's talk was entitled: 'Causal by design: genetics-first discovery combined with agentic AI as the engine of next-generation therapeutics'.
Genomics retweeted
Can AI make drug discovery faster, safer and more successful?
UK TechBio company @Genomicsltd has launched Mystra AI, an agentic platform using large-scale human genetics data to help identify and validate drug targets.
A sign of how the UK is combining genomics, AI and life sciences to shape the future of medicine.
politicsuk.com/news/techbio-…
Bringing a new drug to market costs $2.3bln. 95% of drug candidates fail. But what if we could fundamentally change this? At #SXSWLondon, we launched #MystraAI - the definitive solution for genetics-based drug target discovery. 🚀#AI #Pharma #Biotech #DrugDiscovery
Our VP of Life Sciences, Alexandra Fish, is a keynote speaker today - 12:00 PM local time - at #FOGBoston. Find her on the AI in Drug Discovery Stage and find out more about Mystra AI! You can find our team on Booth 6. See you there! #FOG
Catch us at #sxswlondon TWICE tomorrow on the Truman Brewery Stage! ✨ AI's Next Frontier: Life Itself
1:55 - 2:35pm (FOR #MEDIA: Join us here for major #news.)
Healthcare Rewired 5:05 - 5:45pm #AI #lifesciences #news #pharma #biotech #healthcare #health #SXSW @SXSW #press
2 days to go! Join us for a live discussion on how AI is being applied to #humangeneticdata for #drugdiscovery & development.
Hear from:
• Alex Eavis, Genomics
• Mike Tarselli, @AWScloud
• Vincent Plagnol, Genomics
21st May 2-3pm BST | 9-10AM EDT
eu1.hubs.ly/H0vkkF60
⏳ One week to go! Join our upcoming webinar, AI in Human Genetics: Where it Helps, Where It Doesn’t, and What Really Matters, with experts from Genomics and @awscloud.
21st May 2-3pm BST | 9-10AM EDT
🎫eu1.hubs.ly/H0vkgB80
📢[FOR MEDIA] Genomics and Greywolf Therapeutics Launch Strategic Relationship to Develop First‑in‑Class Treatments for Autoimmune Diseases.
📰Press release: eu1.hubs.ly/H0tX19r0
#Genomics #CompanyNews #IndustryNews #Innovation
For our upcoming webinar, we’re bringing together experts to explore "#AI in #HumanGenetics: Where It Helps, Where It Doesn’t, & What Really Matters"
🎤 Alex Eavis, Chief Product & Tech Officer
🎤 Vincent Plagnol, CSO
🎤 More speakers coming soon 👀
eu1.hubs.ly/H0tVzHR0
We're excited to share that our webinar series #TheGenomicsRevolution is returning on 21st May, starting with:
#AI in #HumanGenetics: Where it Helps, Where it Doesn't, and What Really Matters
📅 21st May
🕰️ 2:00 PM - 3:00 PM BST
👉 Register here: eu1.hubs.ly/H0tLjZz0
We were honoured to attend @thetimes 100 Tech awards, where we celebrated being named one of Britain’s fastest growing private tech companies for the second year in a row. 🏆 #100Tech @genemodeller
